Physician

Adetola Tolulola Haastrup, MD

According to 2025 Medicare claims, Adetola Haastrup, MD (NPI: 1932174588) practices nephrology in the Grand Forks, ND-MN market, with the plurality of this provider's patient population coming from Grand Forks, ND. This provider's primary affiliated billing organization is ALTRU HEALTH SYSTEM (NPI: 1043309552; TIN: 450310462) and primary practice location at 58201-4036. Haastrup is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), CVS ACO (ACO ID: A5407), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Haastrup's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 736 traditional Medicare patients, billed 3,658 HCPCS/CPT codes, and received $256,738 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 8,349 prescription claims across 795 beneficiaries totaling $371,210 in drug costs, led by Jardiance (Empagliflozin). DME data shows 219 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	705	5,005	$248,625
2016	681	4,731	$237,530
2017	700	3,832	$248,839
2018	719	4,029	$245,561
2019	775	3,999	$277,378
2020	750	3,942	$267,899
2021	770	4,009	$317,147
2022	750	4,022	$295,571
2023	755	3,320	$277,866
2024	736	3,658	$256,738

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	480	5,605	$311,606
2016	492	6,325	$376,635
2017	484	6,749	$458,312
2018	487	6,716	$451,889
2019	524	7,543	$436,500
2020	549	7,178	$372,138
2021	558	7,128	$307,446
2022	627	7,527	$338,475
2023	779	7,848	$339,929
2024	795	8,349	$371,210

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	18	$320
2016	N/R	71	$1,538
2017	N/R	138	$7,919
2018	N/R	278	$19,673
2019	N/R	259	$12,434
2020	N/R	188	$9,128
2021	N/R	232	$7,891
2022	N/R	332	$11,093
2023	N/R	337	$4,814
2024	N/R	219	$3,092

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	136	155	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	496	1,084	$67
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	219	804	$59
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	87	168	$36
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	287	442	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	107	3,823	$73,395
Lokelma	Sodium Zirconium Cyclosilicate	43	1,348	$36,010
Cinacalcet Hcl	Cinacalcet Hcl	84	2,844	$24,260
Bumetanide	Bumetanide	466	22,312	$17,090
Farxiga	Dapagliflozin Propanediol	43	878	$17,012

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	77	$941
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	57	$585
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	13	$568
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	31	$527
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	24	$461

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Adetola Tolulola Haastrup, MD?

Tedicare shows public-source Medicare data for Adetola Tolulola Haastrup, MD (NPI 1932174588), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adetola Tolulola Haastrup, MD have ACO affiliation data?

Adetola Tolulola Haastrup, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), CVS ACO (MSSP, ACO ID A5407), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Adetola Tolulola Haastrup, MD?

Adetola Tolulola Haastrup, MD is linked to ALTRU HEALTH SYSTEM (billing NPI 1043309552) in the available physician profile data.

Does Adetola Tolulola Haastrup, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.